5 Results

People

  1. Scordo
    Scordo
  2. Vardhana
    Vardhana
  3. Perales
    Perales
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Daniyan
    Daniyan
  7. Devlin
    Devlin
  8. Falchi
    Falchi
  9. Horwitz
    Horwitz
  10. Korde
    Korde

Groups

  1. Bone Marrow Transplant (5)
  2. CTCR Scholars (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. Human Oncology and Pathogenesis Program (5)
  7. Lymphoma (5)
  8. GSK Faculty (4)
  9. Survivorship Research (4)
  10. Adult Leukemia (3)
  1. "Center for Hematologic Malignancies"
  2. "Human Oncology and Pathogenesis Program"
  3. "Lymphoma"
  4. "Michael Scordo"
Formats
  1. Journal Article (2)
  2. Guidelines (1)
  3. Meeting Abstract (1)
  4. Research Letter (1)
Groups
  1. Bone Marrow Transplant (5)
  2. CTCR Scholars (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Michael Scordo (5)
  2. Santosha Vardhana (4)
  3. Gunjan Shah (3)
  4. Miguel-Angel Perales (3)
  5. Alison Moskowitz (2)
  6. Andrew Zelenetz (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
Publications
  1. Blood (1)
  2. Cancer Cell (1)
  3. JNCI: Journal of the National Cancer Institute (1)
  4. Journal of Clinical Investigation (1)
  5. Scientific Reports (1)
Publishers
  1. American Society for Clinical Investigation (1)
  2. American Society of Hematology (1)
  3. Cell Press (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Recommendations for testing and treating outpatient cancer patients in the era of COVID-19
    Guidelines

    Reidy-Lagunes, D.; Saltz, L.; Postow, M.; Scordo, M.; Moskowitz, A.; Tew, W.; Zamarin, D.; Redelman-Sidi, G.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Oncologic immunomodulatory agents in patients with cancer and COVID-19
    Journal Article

    Jee, J.; Stonestrom, A. J.; Devlin, S.; Nguyentran, T.; Wills, B.; Narendra, V.; Foote, M. B.; Lumish, M.; Vardhana, S. A.; Pastores, S. M.; more...
    Scientific Reports (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
    Journal Article

    Shah, G. L.; DeWolf, S.; Lee, Y. J.; Tamari, R.; Dahi, P. B.; Lavery, J. A.; Ruiz, J.; Devlin, S. M.; Cho, C.; Peled, J. U.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save